Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|4|2|139-148

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.2, 2004-03, pp. : 139-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor inhibitors in cancer treatment

By Ciardiello Fortunato  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 221-234

Future Medicine

Access to resources Recommend Favorite

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro   Chevalier Thierry  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1040-1048

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Signaling in Nonsmall Cell Lung Cancer

By Ganti Apar Kishor  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 515-525

Informa Healthcare

Access to resources Recommend Favorite